Insider Stock Trading History of Celentano John E


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Celentano John E since year 2005. The trader's CIK number is 1346102. At the time of this reporting, Celentano John E is the Director of Bristol Myers Squibb Co . (stock ticker symbol (BMY)). See this page for all insider trading activities at Bristol Myers Squibb Co .

Note that in the past Celentano John E also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Celentano John E since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2012-03-06 BMY Bristol Myers Squibb Co Option Ex 32,330 .00 0
2012-03-04 BMY Bristol Myers Squibb Co Option Ex 2,660 .00 0
2012-03-01 BMY Bristol Myers Squibb Co Option Ex 3,240 .00 0
2012-03-02 BMY Bristol Myers Squibb Co Option Ex 3,495 .00 0
2012-03-03 BMY Bristol Myers Squibb Co Option Ex 2,960 .00 0
2011-05-12 BMY Bristol Myers Squibb Co Sale 22,800 28.53 650,461
2011-05-10 BMY Bristol Myers Squibb Co Sale 3,700 28.81 106,597
2011-05-12 BMY Bristol Myers Squibb Co Option Ex 136,955 28.63 3,921,569
2011-03-04 BMY Bristol Myers Squibb Co Option Ex 2,660 .00 0
2011-03-06 BMY Bristol Myers Squibb Co Option Ex 4,257 .00 0
2011-03-02 BMY Bristol Myers Squibb Co Option Ex 3,494 .00 0
2011-03-01 BMY Bristol Myers Squibb Co Option Ex 42,972 .00 0
2010-09-10 BMY Bristol Myers Squibb Co Option Ex 221,580 23.64 5,238,151
2010-09-10 BMY Bristol Myers Squibb Co Sale 205,700 27.04 5,561,922
2010-03-06 BMY Bristol Myers Squibb Co Option Ex 4,256 .00 0
2010-03-02 BMY Bristol Myers Squibb Co Option Ex 20,909 .00 0
2010-02-25 BMY Bristol Myers Squibb Co Sale 10,752 24.35 261,811
2009-02-17 MJN Mead Johnson Nutrition Co Buy 1,000 24.00 24,000
2007-05-15 BMY Bristol Myers Squibb Co Option Ex 4,501 28.90 130,078
2006-05-30 BMY Bristol Myers Squibb Co Sale 2,328 24.92 58,002

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Celentano John E (Director of Bristol Myers Squibb Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.